BRCA || Public Health Genomics Knowledge Base (v1.2)

Public Health Genomics Knowledge Base (v1.2)







Last Updated: Oct 27, 2016

• "Maybe they have found something new" participants' views on returning cohort psychosocial survey results.
  Bureau Eve et al. Health expectations : an international journal of public participation in health care and health policy 2015 Dec 18(6) 2425-36
• BRACAVENIR - impact of a psychoeducational intervention on expectations and coping in young women (aged 18-30 years) exposed to a high familial breast/ovarian cancer risk: study protocol for a randomized controlled trial.
  Kwiatkowski Fabrice et al. Trials 2016 Oct 17(1) 509
• Communicating BRCA research results to patients enrolled in international clinical trials: lessons learnt from the AGO-OVAR 16 study.
  Pulford David J et al. BMC medical ethics 2016 Oct 17(1) 63
• New Study Highlights the Benefits of BRCA Testing for All People of Ashkenazi Jewish Descent
  Current Screening Standards May Miss BRCA Carriers with Significant Cancer Risk, Newswise, October 20, 2016
• The transfer of multigene panel testing for hereditary breast and ovarian cancer to healthcare: What are the implications for the management of patients and families?
  Eliade Marie et al. Oncotarget 2016 Oct
• Outcome of ovarian cancer after breast cancer in BRCA1 and BRCA2 mutation carriers.
  Zaaijer Leendert H, et al. British journal of cancer 2016 10
• Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations.
  Alemar Bárbara, et al. Cancer genetics 2016 9 (9) 417-422
• Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-Label Studies.
  Dirix Luc, et al. Clinical therapeutics 2016 10
• Experiences from a pilot program bringing BRCA1/2 genetic screening to theUS Ashkenazi Jewish population.
  Wiesman Chana et al. Genetics in medicine : official journal of the American College of Medical Genetics 2016 Oct
• Identification and management of women with a family history of breast cancer: Practical guide for clinicians.
  Heisey Ruth et al. Canadian family physician Medecin de famille canadien 2016 Oct 62(10) 799-803
• Experiences from a pilot program bringing BRCA1/2 genetic screening to theUS Ashkenazi Jewish population
  C Wiesman et al, Genetics in Medicine, October 14, 2016
• Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
  Mirza Mansoor R, et al. The New England journal of medicine 2016 10
• Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.
  Solbrække Kari Nyheim et al. Medicine, health care, and philosophy 2016 Oct
• The Life Course Perspective: a Guide for Genetic Counselors.
  Hamilton Rebekah J et al. Journal of genetic counseling 2016 Feb 25(1) 44-8
• BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis.
  Zhu Yaning, et al. Oncotarget 2016 9

• CDC Information (4)
• CDC-Authored Pub (2)

• Human (51)
• Pathogen (0)

• Human (490)
• Pathogen (0)

• Human (146)
• Pathogen (0)

• Guidelines (7)
• Tier Table (3)
• Synthesis (7)

• Huamn (27)
• Pathogen (0)

Relevant Resources

• Cancer Genomics and Epidemiology Navigator (CGEN)
• Genetics and Genomics Competencies Center (G2C2)
• NIH Genetic Testing Registry
• NIH MedGen Database
• Online Mendelian Inheritance in Man (OMIM)
• PharmGKB